| Therapeutic drug monitoring of long-acting injectable antipsychotic drugs G Schoretsanitis, P Baumann, A Conca, O Dietmaier, G Giupponi, ... Therapeutic drug monitoring 43 (1), 79-102, 2021 | 32 | 2021 |
| Therapeutic reference ranges for psychotropic drugs: a protocol for systematic reviews XM Hart, L Eichentopf, X Lense, T Riemer, K Wesner, C Hiemke, ... Frontiers in Psychiatry 12, 787043, 2021 | 27 | 2021 |
| Therapeutic reference range for aripiprazole in schizophrenia revised: a systematic review and metaanalysis XM Hart, C Hiemke, L Eichentopf, XM Lense, HW Clement, A Conca, ... Psychopharmacology 239 (11), 3377-3391, 2022 | 22 | 2022 |
| Molecular imaging of dopamine partial agonists in humans: implications for clinical practice XM Hart, CN Schmitz, G Gründer Frontiers in Psychiatry 13, 832209, 2022 | 22 | 2022 |
| Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence L Cellini, D De Donatis, G Zernig, D De Ronchi, G Giupponi, A Serretti, ... International Clinical Psychopharmacology 37 (2), 29-37, 2022 | 17 | 2022 |
| Is therapeutic drug monitoring relevant for antidepressant drug therapy? Implications from a systematic review and meta-analysis with focus on moderating factors CSM Funk, XM Hart, G Gründer, C Hiemke, B Elsner, R Kreutz, TG Riemer Frontiers in Psychiatry 13, 826138, 2022 | 13 | 2022 |
| Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy L Eichentopf, C Hiemke, A Conca, J Engelmann, M Gerlach, ... Frontiers in Psychiatry 13, 972141, 2022 | 10 | 2022 |
| Behind the curtain: therapeutic drug monitoring of psychotropic drugs from a laboratory analytical perspective M Scherf-Clavel, P Baumann, XM Hart, H Schneider, G Schoretsanitis, ... Therapeutic Drug Monitoring, 10.1097, 2022 | 8 | 2022 |
| Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder XM Hart, S Heesen, CN Schmitz, S Dörfler, D Wedekind, G Gründer, ... European Archives of Psychiatry and Clinical Neuroscience 273 (1), 75-83, 2023 | 7 | 2023 |
| Therapeutic reference range for olanzapine in schizophrenia: systematic review on blood concentrations, clinical effects, and dopamine receptor occupancy K Wesner, C Hiemke, N Bergemann, KM Egberts, S Fekete, M Gerlach, ... The Journal of Clinical Psychiatry 84 (5), 47964, 2023 | 6 | 2023 |
| Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis XM Lense, C Hiemke, CSM Funk, U Havemann-Reinecke, G Hefner, ... Psychopharmacology 241 (2), 275-289, 2024 | 5 | 2024 |
| Low escitalopram concentrations in patients with depression predict treatment failure: a naturalistic retrospective study XM Hart, F Amann, J Brand, L Eichentopf, G Gründer Pharmacopsychiatry 56 (02), 73-80, 2023 | 3 | 2023 |
| Therapeutic reference range for aripiprazole revised: a systematic review and combined analysis XM Hart, C Hiemke, HW Clement, A Conca, L Eichentopf, F Faltraco, ... Pharmacopsychiatry 55 (03), 10, 2022 | 3 | 2022 |
| Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants XM Hart, M Spangemacher, J Defert, H Uchida, G Gründer Therapeutic Drug Monitoring, 10.1097, 2022 | 2 | 2022 |
| Update lessons from positron emission tomography imaging Part I: a systematic critical review on therapeutic plasma concentrations of antipsychotics XM Hart, M Spangemacher, H Uchida, G Gründer Therapeutic Drug Monitoring, 10.1097, 2022 | 2 | 2022 |
| P. 496 Case report: therapeutic drug monitoring in a female schizophrenia patient with self-induced clozapine intoxication using point-of-care testing XM Hart, RAA Konietzko, D Hirjak, G Gruender European Neuropsychopharmacology 40, S278, 2020 | 2 | 2020 |
| Neue und experimentelle medikamentöse Therapieverfahren LJ Mertens, X Hart, DJ Scharf, M Spangemacher, G Gründer Therapieresistenz bei Depressionen und bipolaren Störungen, 203-218, 2023 | 1 | 2023 |
| Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination N Wendler, M Spangemacher, K Böttcher, D Hirjak, G Gründer, XM Hart Pharmacopsychiatry 55 (03), 23, 2022 | 1 | 2022 |
| P. 0693 Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range L Eichentopf, C Hiemke, G Hefner, G Schoretsanitis, M Kuzin, G Zernig, ... | 1 | 2021 |
| Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics XM Hart, G Gründer, N Ansermot, A Conca, E Corruble, S Crettol, ... The World Journal of Biological Psychiatry, 1-123, 2024 | | 2024 |
